Literature DB >> 8113896

Visualization of damaged brain tissue after ischemic stroke with cobalt-55 positron emission tomography.

H M Jansen1, J Pruim, A M vd Vliet, A M Paans, J M Hew, E J Franssen, B M de Jong, J G Kosterink, R Haaxma, J Korf.   

Abstract

UNLABELLED: In animal experiments, the radionuclide 55Co2+ has been shown to accumulate in degenerating cerebral tissue similar to Ca2+.
METHODS: The potential role of 55Co2+ for in vivo brain PET imaging was investigated in four patients after ischemic stroke.
RESULTS: PET showed uptake of 55Co2+ in damaged brain tissue irrespective of blood-brain barrier integrity, as affirmed by CT and MRI.
CONCLUSION: Our preliminary results indicate that 55CoCl2 may prove to be a useful and relatively inexpensive PET radiopharmaceutical for visualization of degenerative processes in brain tissue.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8113896

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  6 in total

1.  Cyclotron production and radiochemical separation of 55Co and 58mCo from 54Fe, 58Ni and 57Fe targets.

Authors:  H F Valdovinos; R Hernandez; S Graves; P A Ellison; T E Barnhart; C P Theuer; J W Engle; W Cai; R J Nickles
Journal:  Appl Radiat Isot       Date:  2017-09-06       Impact factor: 1.513

2.  Cobalt-55 positron emission tomography in traumatic brain injury: a pilot study.

Authors:  H M Jansen; J van der Naalt; A H van Zomeren; A M Paans; L Veenma-van der Duin; J M Hew; J Pruim; J M Minderhoud; J Korf
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-02       Impact factor: 10.154

Review 3.  Non-invasive radionuclide imaging of trace metal trafficking in health and disease: "PET metallomics".

Authors:  George Firth; Julia E Blower; Joanna J Bartnicka; Aishwarya Mishra; Aidan M Michaels; Alex Rigby; Afnan Darwesh; Fahad Al-Salemee; Philip J Blower
Journal:  RSC Chem Biol       Date:  2022-04-11

Review 4.  PET radiometals for antibody labeling.

Authors:  Eduardo Aluicio-Sarduy; Paul A Ellison; Todd E Barnhart; Weibo Cai; Robert Jerry Nickles; Jonathan W Engle
Journal:  J Labelled Comp Radiopharm       Date:  2018-03-12       Impact factor: 1.921

5.  Evaluation of the radiocobalt-labeled [MMA-DOTA-Cys61]-Z HER2:2395(-Cys) affibody molecule for targeting of HER2-expressing tumors.

Authors:  Helena Wållberg; Sara Ahlgren; Charles Widström; Anna Orlova
Journal:  Mol Imaging Biol       Date:  2009-06-26       Impact factor: 3.488

6.  High Contrast PET Imaging of GRPR Expression in Prostate Cancer Using Cobalt-Labeled Bombesin Antagonist RM26.

Authors:  Bogdan Mitran; Helge Thisgaard; Ulrika Rosenström; Johan Hygum Dam; Mats Larhed; Vladimir Tolmachev; Anna Orlova
Journal:  Contrast Media Mol Imaging       Date:  2017-08-10       Impact factor: 3.161

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.